Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs 5,427
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Pipeline programs

Page 57 of 114

  1. LOXO-BTK-20030

    Wuhan Createrna Science and Technology Co., Ltd

    Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

    phase 3 small molecule active

    1 trial

  2. LP0162-1336

    LEO Pharma A/S

    Treatment of moderate-to-severe Atopic dermatitis

    phase 3 small molecule active

    1 trial

  3. LP352-301

    Lacuna Pharma Pty Ltd

    Developmental and Epileptic Encephalopathies (DEE)

    phase 3 small molecule active

    1 trial

  4. LP352-302

    Lacuna Pharma Pty Ltd

    Dravet Syndrome

    phase 3 small molecule active

    1 trial

  5. LP352-303

    Lacuna Pharma Pty Ltd

    Developmental and Epileptic Encephalopathies (DEEs)

    phase 3 small molecule active

    1 trial

  6. LTE15174

    Genzyme Europe B.V.

    Hemophilia A or Hemophilia B

    phase 3 small molecule active

    1 trial

  7. LTFU-ABO-102

    Lacuna Pharma Pty Ltd

    Mucopolysaccharidosis type IIIA

    phase 3 small molecule active

    1 trial

  8. LTS17043

    Sanofi-aventis Healthcare Pty Ltd

    Nervous system diseases

    phase 3 small molecule active

    1 trial

  9. LTS17043

    Sanofi-aventis Healthcare Pty Ltd

    Nervous system diseases

    phase 3 small molecule active

    1 trial

  10. LTS17367

    Sanofi-aventis Healthcare Pty Ltd

    Dermatitis atopic

    phase 3 small molecule active

    1 trial

  11. LUM

    Vertex Pharmaceuticals (Australia) Pty.

    Cystic Fibrosis

    phase 3 small molecule completed

    1 trial

  12. LUM-201-10

    Lacuna Pharma Pty Ltd

    Growth Hormone Deficiency (GHD)

    phase 3 small molecule active

    1 trial

  13. LV305

    Lxo Ireland Designated Activity Company

    Synovial Sarcoma

    phase 3 mab terminated

    1 trial

  14. LY06006/MRCT-301

    Wuhan Createrna Science and Technology Co., Ltd

    Postmenopausal osteoporosis

    phase 3 small molecule active

    1 trial

  15. LY2127399

    Eli Lilly and Company

    Rheumatoid Arthritis

    phase 3 small molecule terminated

    1 trial

  16. LY2127399

    Eli Lilly and Company

    Systemic Lupus Erythematosus

    phase 3 small molecule completed

    1 trial

  17. LY2189265

    United Therapeutics Europe Ltd

    Diabetes Mellitus, Type 2

    phase 3 small molecule completed

    1 trial

  18. LY2216684

    Eli Lilly and Company

    Major Depressive Disorder

    phase 3 small molecule completed

    1 trial

  19. LY3819253

    Vir Biotechnology

    Covid19

    phase 3 mab completed

    1 trial

  20. Lactobacillus plantarum

    United Therapeutics Europe Ltd

    Constipation - Functional

    phase 3 small molecule completed

    1 trial

  21. Lactobacillus plantarum IS-10506

    United Therapeutics Europe Ltd

    Constipation - Functional

    phase 3 small molecule completed

    1 trial

  22. Lactose Placebo

    United Therapeutics Europe Ltd

    Elbow Fracture

    phase 3 small molecule completed

    1 trial

  23. Lactose monohydrate for Chronic low back pain

    Disc Medicine

    Chronic low back pain

    phase 3 small molecule active

    1 trial

  24. Lanadelumab

    Takeda

    Hereditary Angioedema

    phase 3 small molecule completed

    1 trial

  25. Lanadelumab

    Takeda

    Hereditary Angioedema (HAE)

    phase 3 small molecule completed

    2 trials

  26. Lanadelumab

    Takeda

    Angioedema

    phase 3 small molecule completed

    2 trials

  27. Lansoprazole

    Takeda

    Stomach Ulcer

    phase 3 small molecule completed

    2 trials

  28. Lansoprazole and naproxen and aspirin

    Takeda

    Osteoarthritis

    phase 3 small molecule completed

    1 trial

  29. Lansoprazole microgranules suspension

    Takeda

    Gastroesophageal Reflux Disease

    phase 3 small molecule completed

    1 trial

  30. Lapaquistat Acetate

    Takeda

    Dyslipidemia

    phase 3 small molecule completed

    2 trials

  31. Lapaquistat acetate

    Takeda

    Hypercholesterolemia

    phase 3 small molecule completed

    4 trials

  32. Lapaquistat acetate and atorvastatin

    Takeda

    Hypercholesterolemia

    phase 3 small molecule completed

    2 trials

  33. Lapaquistat acetate and current lipid-lowering treatment

    Takeda

    Hypercholesterolemia

    phase 3 small molecule terminated

    1 trial

  34. Lapaquistat acetate and lipid-lowering therapy

    Takeda

    Type 2 Diabetes

    phase 3 small molecule completed

    1 trial

  35. Lapaquistat acetate and rosuvastatin

    Takeda

    Hypercholesterolemia

    phase 3 small molecule completed

    1 trial

  36. Lapaquistat acetate and simvastatin

    Takeda

    Hypercholesterolemia

    phase 3 small molecule completed

    2 trials

  37. Lapaquistat acetate and stable statin therapy

    Takeda

    Hypercholesterolemia

    phase 3 small molecule terminated

    2 trials

  38. Lapatinib

    Novartis Pharmaceuticals

    Breast Neoplasms

    phase 3 small molecule completed

    1 trial

  39. Lapatinib

    Novartis Pharmaceuticals

    Neoplasms, Breast

    phase 3 small molecule terminated

    2 trials

  40. Lapatinib

    GlaxoSmithKline

    Neoplasms, Head and Neck

    phase 3 small molecule completed

    1 trial

  41. Laquinimod

    Teva Pharma GmbH

    Multiple Sclerosis

    phase 3 small molecule completed

    3 trials

  42. Laquinimod

    Teva Pharma GmbH

    Relapsing Multiple Sclerosis

    phase 3 small molecule terminated

    2 trials

  43. Laquinimod

    Teva Pharma GmbH

    Relapsing Remitting Multiple Sclerosis

    phase 3 small molecule terminated

    2 trials

  44. Learning Session

    BRIGHT MINDS BIOSCIENCES INC.

    Addiction

    phase 3 other completed

    1 trial

  45. Lebrikizumab

    Eli Lilly and Company

    Atopic Dermatitis

    phase 3 mab completed

    1 trial

  46. Lecanemab

    Eisai Co.,

    Mild cognitive impairment due to Alzheimer's disease or mild Alzheimer's disease dementia.

    phase 3 small molecule active

    1 trial

  47. Leflunomide Mylan for polymyalgia rheumatica

    Disc Medicine

    polymyalgia rheumatica

    phase 3 small molecule active

    1 trial

  48. Lenabasum 20 mg

    Corbus Pharmaceuticals Holdings

    Dermatomyositis

    phase 3 small molecule completed

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.